Subscribe free

Metabolic and Bariatric Surgery ·

Endoscopic sleeve gastroplasty shows comparable outcomes to surgery

A retrospective analysis of patients undergoing endoscopic sleeve gastroplasty (ESG) versus laparoscopic sleeve gastrectomy (LSG) revealed similar improvements in obesity-related comorbidities. While LSG resulted in greater percentage total body weight loss at 6 months, 1 year, and 2 years, ESG was associated with shorter hospital stays and fewer severe adverse events. Patients undergoing ESG were also older and less obese compared to those receiving LSG, indicating its viability as a less invasive weight loss option.

Journal Article by Joseph S, Vandruff VN (…) Ujiki MB et 8 al. in Surg Endosc

© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

read the whole article in Surg Endosc

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Metabolic and Bariatric Surgery.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Metabolic and Bariatric Surgery

The latest stitches

Surg Endosc29 Sep 2026

Endoscopic Sleeve Gastroplasty Offers Safer Alternative to LSG

Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).

All papers in Metabolic and Bariatric Surgery →